SamanTree Medical
PrivateLast Round
Debt
Jan 27, 2026
Total Funding Raised
$60.63M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
SamanTree Medical operates in Healthcare & Life Sciences and is based in Lausanne. Its latest recorded funding round was a Debt round in January 2026.
SamanTree Medical is a medical device company that develops and commercializes the Histolog® Scanner, a digital microscopy device for real-time imaging of excised tissue during oncologic surgery.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Medical Imaging, Medical AI
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
SamanTree Medical Comparables
Compare SamanTree Medical with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| VivaScope GmbH | 84% | |
| Invenio Imaging | 83% | |
| OncoRes Medical | 83% |
For institutional investors. Book with your work email.
SamanTree Medical Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Debt | Jan 27, 2026 | ||||
| Series B Extension | Apr 8, 2025 | ||||
| Series B | Jul 16, 2024 | ||||
| Series A | May 7, 2019 | ||||
| Grant | Sep 1, 2018 | ||||
Debt | Jun 27, 2018 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
SamanTree Medical Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| European Innovation Council Fund | Grant |
| Foundation for Technological Innovation | Debt |
| Sioux Tech Fund | Series A |
| Noshaq | Series B Extension, Series B |
| Brabantse Ontwikkelings Maatschappij | Series B Extension, Series B |
| Wallonie Entreprendre | Series B |
| Turenne Groupe | Series B |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 17, 2026
Grew 20% QoQ, from 50 to 60 employees.
- Jan 27, 2026
$24M debt round completed.
For institutional investors. Book with your work email.
SamanTree Medical Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about SamanTree Medical's valuation, stock price, and market status.
Is SamanTree Medical a public or private company?
SamanTree Medical is a private company.
What is the current stock price of SamanTree Medical?
SamanTree Medical is a private company, so its shares have no public market price. Caplight tracks SamanTree Medical's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is SamanTree Medical worth (valuation)?
Valuation information for SamanTree Medical is not publicly available.
Can I buy SamanTree Medical stock?
SamanTree Medical shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was SamanTree Medical's last funding round?
SamanTree Medical's most recent funding round was Debt on January 27, 2026.
Who are the main investors in SamanTree Medical?
Key investors in SamanTree Medical include European Investment Bank Group, Turenne Capital Partenaires, Panakès Partners, Karista.
Will SamanTree Medical IPO soon?
No public IPO plans have been announced for SamanTree Medical.
How can I track SamanTree Medical secondary market activity?
Caplight tracks bids, offers, and trades in SamanTree Medical's shares on secondary markets.